Skip to content
Open in App
IDEXX Laboratories logo

IDEXX Laboratories

web2

IDEXX Laboratories, Inc. develops, manufactures, and distributes products for the companion ani...

Symbol · 1IDXX
Company profile

About

IDEXX Laboratories, Inc. develops, manufactures, and distributes products for the companion animal veterinary, livestock and poultry, dairy, and water testing industries in the United States and internationally. It operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. The company offers point-of-care diagnostic solutions, blood and urine chemistry, hematology, immunoassay, urinalysis, cytology/morphology, and coagulation analyzers; and SNAP rapid assays test kits. It also provides commercial reference laboratory diagnostic and consulting services to veterinarians; veterinary consultation, telemedicine, and advisory services, including radiology, dental radiography, cardiology, internal medicine, and ultrasound consulting; Colilert, Colilert-18, and Colisure tests, which detect the presence of total coliforms and E. coli in water; Enterolert, Pseudalert, Filta-Max and Filta-Max xpress, Legiolert, Quanti-Tray products, and Tecta system instruments; UV Viewer Plus, a UV light cabinet which aids in the visual interpretation of fluorescent-based water tests; and veterinary software and services for independent veterinary clinics and corporate groups. In addition, the company offers diagnostic tests, services, and related instrumentation to manage the health status of livestock and poultry; human medical diagnostic products and services; and VetConnect PLUS, a cloud-based technology that enables veterinarians to access and analyze patients, as well as operates VetLab Station. It markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers. IDEXX Laboratories, Inc. was incorporated in 1983 and is headquartered in Westbrook, Maine.

Explore by sector

Explore this sector

Market identity

Exchange listings

Listing identities only. Orbitrum does not publish live prices or market performance on this public profile.

Progress

Roadmap

Michael Erickson becomes President and CEO of IDEXX

KEY STEP

IDEXX announced that Michael Erickson will assume the roles of President and Chief Executive Officer on May 12, 2026. Jay Mazelsky will transition to Executive Chair of the Board as part of the planned leadership succession.

Roadmap reference
People

Company team

JL

Joseph L. Hooley

Independent Director

Company leadership profile.

BL

Bruce L. Claflin

Independent Director

Company leadership profile.

JJ

Jonathan J. Mazelsky

Executive Chairman

Company leadership profile.

MG

Michael G. Erickson

CEO, President & Director

Company leadership profile.

SM

Stuart M. Essig

Independent Director

Company leadership profile.

SA

Sam A. Samad

Independent Director

Company leadership profile.

IC

Irene Chang Britt

Independent Director

Company leadership profile.

LD

Lawrence D. Kingsley

Independent Lead Director

Company leadership profile.

SV

Sophie V. Vandebroek

Independent Director

Company leadership profile.

DM

Daniel M. Junius

Independent Director

Company leadership profile.

KA

Karen Alexandra Smith Peacock

Independent Director

Company leadership profile.

Expert coverage

1 expert evaluated IDEXX Laboratories.

Orbitrum research

Experts evaluating IDEXX Laboratories

Explore the public profiles of experts who have evaluated this project.

Orbitrum Academy

Learn how to read a project assessment